JuveLook 1 x 50 mg – Hybrid PDLLA + Hyaluronic Acid Collagen Biostimulator
 
Product Overview
JuveLook is a hybrid injectable biostimulator developed to progressively improve skin quality, texture, elasticity and firmness through the combination of poly-D,L-lactic acid (PDLLA) and non-cross-linked hyaluronic acid (HA).
 
Its dual-action technology combines the initial hydrating and skin-supporting properties of hyaluronic acid with the progressive collagen-stimulating activity of PDLLA microspheres, promoting neocollagenesis and gradual dermal remodelling.
 
Technology & Composition
JuveLook combines PDLLA (poly-D,L-lactic acid) microspheres with high-molecular-weight hyaluronic acid.
 
Each vial contains:
PDLLA: 42.5 mg
Hyaluronic Acid: 7.5 mg
Total content: 50 mg per vial
Uniform PDLLA microspheres
Porous, reticular internal microsphere structure
Thin and porous microsphere wall
Particle size: approximately 10–40 μm
Average particle size: approximately 23 μm
Hyaluronic acid molecular weight: approximately 3,000 kDa
 
The hyaluronic acid component provides initial hydration and acts as a carrier gel, while the biodegradable PDLLA microspheres progressively stimulate endogenous collagen production.
 
Packaging (Contents)
1 vial
Total content: 50 mg
PDLLA: 42.5 mg
Hyaluronic Acid: 7.5 mg
Lyophilised injectable product requiring reconstitution prior to administration
 
Indications & Treatment Areas
JuveLook is designed for treatments focused on improving overall skin quality and correcting superficial skin irregularities through appropriate intradermal or subcutaneous administration.
 
Main applications include:
Skin quality improvement
Fine lines and superficial wrinkles
Loss of skin elasticity
Enlarged pores
Acne scars and atrophic scars
Stretch marks
Uneven skin texture
Skin hydration and luminosity
Facial skin biostimulation
Neck and décolletage treatments, where clinically appropriate
 
Treatment areas, injection depth and technique must always be selected according to the manufacturer's current Instructions for Use and the clinical assessment of the qualified healthcare professional.
 
Clinical Benefits
Progressive stimulation of endogenous collagen production
Improvement in overall skin quality
Improved skin texture and smoothness
Increased firmness and elasticity
Reduction in the appearance of fine lines
Improvement in the appearance of atrophic and acne scars
Improvement in the appearance of enlarged pores
Initial hydration provided by hyaluronic acid
Progressive dermal remodelling
Biodegradable PDLLA technology
Gradual, natural-looking results
 
Treatment Protocol
Treatment protocols should be individualised according to the patient's skin condition, treatment area, clinical indication and professional assessment.
 
A commonly referenced JuveLook protocol consists of:
Initial treatment course: 3 sessions
Interval: approximately 4 weeks between sessions
Subsequent maintenance treatments may be performed according to individual clinical requirements
 
Reconstitution, injection depth, administered volume and injection technique must be performed strictly according to the manufacturer's current Instructions for Use.
 
Duration of Results
JuveLook provides progressive results associated with collagen biostimulation and dermal remodelling.
 
Published product information describes results lasting up to approximately 12 months, although clinical longevity may vary depending on the patient's age, metabolism, skin condition, treatment area, injection technique and number of sessions performed.
Maintenance treatments may be recommended according to individual clinical assessment.
 
Manufacturer & Regulatory Information
Manufacturer: VAIM Co., Ltd. / VAIM Global Inc.
Country of Origin: Republic of Korea
JuveLook is an injectable medical device developed for professional use in aesthetic medicine.
CE-marked medical device for the European market.
 
Manufacturing and quality management processes are conducted under standards applicable to medical devices, including ISO 13485.
In Spain and the European Union, the product must be marketed and used in accordance with applicable European medical device legislation, including Regulation (EU) 2017/745 (MDR), applicable requirements of the AEMPS (Spanish Agency for Medicines and Medical Devices) and the manufacturer's current Instructions for Use.
 
For Professional Use Only
As a trusted distributor within the aesthetic medicine sector, AesthiSave® emphasises that our products are intended exclusively for professional use.
These treatments must only be performed by qualified and appropriately trained healthcare professionals, ensuring the highest standards of patient safety and care.